Effect of ergot alkaloids on 3H-flunitrazepam binding to mouse brain GABAA receptors

Collegium Antropologicum

Volumn 27, Issue SUPPL. 1, 2003, Pages 175-182

  Tvrdeić, Ante ^a   Peričić, Danka ^b  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

3H flunitrazepam; Ergot drugs; GABAA; Mouse

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; DIAZEPAM; DIHYDROERGOCRYPTINE; DIHYDROERGOSINE; DIHYDROERGOTAMINE; DIHYDROERGOTOXINE; ERGOT ALKALOID; FLUMAZENIL; FLUNITRAZEPAM; NEUROTRANSMITTER; THIOPENTAL; ANXIOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN CORTEX; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; IN VITRO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; RECEPTOR BINDING; ANIMAL; BRAIN; CBA MOUSE; METABOLISM;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; BRAIN; ERGOT ALKALOIDS; FEMALE; MICE; MICE, INBRED CBA; RECEPTORS, GABA-A;

EID: 12144286948     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. CHARNEY, D. S., J. MIHIC, R. A. HARRIS, Hypnotics and sedatives. In: HARDMAN, J. G., L. L. LIMBIRD, A. GOODMAN GILMAN (Eds.): Goodman & Gilman's the pharmacological basis of therapeutics. (McGraw Hill, New York, 2001).
2. SIEGHART, W., Pharmacol. Rev., 47 (1995) 181.
3. FALKENSTEIN, E., H. C. TILLMAN, M. CHRIST, M. FEURING, M. WEHLING, Pharmacol. Rev., 52 (2000) 513.
4. HOFMANN, B. B., Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In: HARDMAN, J. G., L. L. LIMBIRD, A. GOODMAN GILMAN (Eds.): Goodman & Gilman's the pharmacological basis of therapeutics. (McGraw Hill, New York, 2001).
5. PERIČIĆ, D., H. MANEV, Psychopharmacology, 80 (1983) 171.
6. PERIČIĆ, D., H. MANEV, J. Neural. Transm., 79 (1990) 125.
7. TVRDEIĆ, A., D. PERIČIĆ, Eur. J. Pharmacol., 221 (1992) 139.
8. PERIČIĆ, D., A. TVRDEIĆ, Eur. J. Pharmacol., 235 (1993) 267.
9. TVRDEIĆ, A., D. PERIČIĆ, Eur. J. Pharmacol., 202 (1991) 109.
10. GORDON - WEEKS, P. R., Isolation of synaptosomes, growth cones and their subcellular components. In: TURNER, A. J., H. S. BACHELARD (Eds.): Neurochemistry: A practical approach. (IRL Press, Oxford, 1987).
11. LOWERY, O. H., N. J. ROSEBROUGH, A. L. FARR, R. J. RANDALL, J. Biol. Chem., 193 (1951), 265.
12. ZARKOVSKY, A. M., Neuropharmacology, 26 (1987) 1653.
13. McPHERSON, G. A., Comput. Prog. Biomed., 17 (1983) 107.
14. TALLARIDA, R. J., R. B. MURAY: Manual of pharmacologic calculationas with computer programs. (Springer Verlag, New York, 1986).
15. WONG, P. T. H., Can. J. Physiol. Pharmacol., 69 (1991) 109.
16. DE LOREY, T. M., G. B. BROWN, J. Neurochem., 58 (1992) 2162.
17. MAGUIRE, P. A., H. O. VILLAR, M. F. DAVIES, G. H. LOEW, Eur. J. Pharmacol., 226 (1992) 233.
18. BROWN, C. L., I. L. MARTIN, Eur. J. Pharmacol., 106 (1985) 167.
19. COSTA, E., Neuropsychopharmacology, 2 (1989) 167.
20. ENNA, S. J., S. H. SNYDER, Mol. Pharmacol., 13 (1977) 442.
21. KAROBATH, M., G. SPERK, Proc. Natl. Acad. Sci., 76 (1979) 1004.
22. THYAGARAJAN, R., R. RAMNJANEYULU, M. K. TICKU, J. Neurochem., 41 (1983) 578.
23. GEE, K. W., Mol. Neurobiol., 2 (1988) 291.
24. BUREAU, M. H., R. W. OLSEN, J. Neurochem., 61 (1993) 1479.
25. PRICE, R. J., M. A. SIMMONDS, Neurosci. Lett., 135 (1992) 273.
26. HRUSKA, R. E., E. K. SILBERGELD, J. Neurosci., 6 (1981) 1.